Brandon R. Rosen

发表

Total Synthesis of Dixiamycin B by Electrochemical Oxidation

Phil S. Baran, Alexander G. O’Brien, P. Baran, 2014, Journal of the American Chemical Society.

Scalable and Sustainable Electrochemical Allylic C–H Oxidation

Ke Chen, Phil S. Baran, Martin D. Eastgate, 2016, Nature.

Synthetic Organic Electrochemistry: An Enabling and Innately Sustainable Method

Phil S. Baran, P. Baran, Brandon R. Rosen, 2016, ACS central science.

C-H functionalization logic enables synthesis of (+)-hongoquercin A and related compounds.

Peter S. Thuy-Boun, P. Baran, jin-quan yu, 2013, Angewandte Chemie.

Enantioconvergent synthesis of (+)-aphanorphine via asymmetric Pd-catalyzed alkene carboamination.

J. Wolfe, Brandon R. Rosen, D. N. Mai, 2011, Organic letters.

Use of aryl chlorides as electrophiles in Pd-catalyzed alkene difunctionalization reactions.

J. Wolfe, Brandon R. Rosen, J. Ney, 2010, The Journal of organic chemistry.

New strategy for the synthesis of substituted morpholines.

J. Wolfe, Brandon R. Rosen, Matthew L. Leathen, 2009, The Journal of organic chemistry.

Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts.

J. C. Ruble, Brandon R. Rosen, T. Beauchamp, 2011, Organic letters.

Development of a Scalable and Practical Synthesis of AB928, a Dual A2a/A2b Receptor Antagonist

J. Powers, Brandon R. Rosen, D. Miles, 2020 .

Discovery of AB680 - A Potent and Selective Inhibitor of CD73.

N. Walker, N. Sträter, Lijuan Fu, 2020, Journal of medicinal chemistry.

Improved synthesis of sterically encumbered heteroaromatic biaryls from aromatic β-keto esters

J. Powers, Brandon R. Rosen, D. Miles, 2020 .

Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression

F. Soriano, U. Schindler, J. Powers, 2019, Maintenance of Immune Balance: Effects of Targeted and Immune Therapies.

Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer

A. Becker, J. Jaén, J. Powers, 2017 .

Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.

N. Walker, N. Sträter, J. Powers, 2021, Journal of medicinal chemistry.